Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone

Neurofibromatosis type I is a common tumor predisposing disease in humans. Surgical therapy can be applied only in selected patients with resectable masses. Hence, development of new therapies for this disease is urgent. We used human neurofibroma implants in mice with severe combined immunodeficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Babovic-Vuksanovic, Dusica, Petrovic, Lydia, Knudsen, Bruce E., Plummer, Timothy B., Parisi, Joseph E., Babovic, Srdan, Platt, Jeffrey L.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548804/
https://www.ncbi.nlm.nih.gov/pubmed/15240917
http://dx.doi.org/10.1155/S1110724304308107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548804/
https://www.ncbi.nlm.nih.gov/pubmed/15240917
http://dx.doi.org/10.1155/S1110724304308107

Ejemplares similares